Kopmar, N. E., Gooley, T. A., Roloff, G. W., Zhang, A., Aldoss, I., Lin, C., … Cassaday, R. D. (2025). Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. Blood Immunology & Cellular Therapy, 100028–100028. https://doi.org/10.1016/j.bict.2025.100028

Kopmar, Noam E., Ted A. Gooley, Gregory W. Roloff, Amy Zhang, Ibrahim Aldoss, Chenyu Lin, Evandro Bezerra, et al. “Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.” Blood Immunology & Cellular Therapy, December 2025, 100028–100028. https://doi.org/10.1016/j.bict.2025.100028.

Kopmar NE, Gooley TA, Roloff GW, Zhang A, Aldoss I, Lin C, et al. Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. Blood Immunology & Cellular Therapy. 2025 Dec;100028–100028.

Kopmar, Noam E., et al. “Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.” Blood Immunology & Cellular Therapy, Elsevier BV, Dec. 2025, pp. 100028–100028. Crossref, doi:10.1016/j.bict.2025.100028.

Kopmar NE, Gooley TA, Roloff GW, Zhang A, Aldoss I, Lin C, Bezerra E, Muhsen I, Jeyakumar N, Dykes KC, O’Connor T, Tang K, Chen EC, Connor M, Frey NV, Gordillo CA, Hilal T, Al Darobi AH, Hoeg RT, Irizarry Gatell VM, Valtis YK, Jackson CW, Kota VK, Koura D, Boccucci J, Guzowski C, Kumaran MV, Ladha A, Lee CJ, Majhail NS, Malik SA, Mathews J, Miller K, Moore J, Mountjoy L, O’Dwyer KM, Odstrcil Bobillo S, Oliai CH, Oluwole OO, Pradeep R, Othman T, Ramakrishnan A, Reshef R, Sasine J, Vasu S, Schwartz M, Shaughnessy P, Stefan M, Stock W, Sutherland KC, Tan V, Solh MM, Tracy S, Luskin M, Logan AC, Leonard JT, Hill L, Tsai SB, Advani AS, Ulrickson M, Bachanova V, Dholaria B, Park JH, Battiwalla M, Faramand R, Shah BD, Yaghmour G, Muffly LS, Cassaday RD. Toxicity of Brexucabtagene Autoleucel as a Standard Therapy for Adults with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia. Blood Immunology & Cellular Therapy. Elsevier BV; 2025 Dec;100028–100028.